Biogen (BIIB) Non-Current Assets (2009 - 2026)
Biogen's Non-Current Assets came in at $24.78 billion for Q2 2026, up 21.7% from $20.36 billion a year earlier and up 22.1% from the prior quarter.
Powered by 
Analysis
Biogen (BIIB) Non-Current Assets (2009 - 2026) Analysis & Trends
At the end of FY2025, Biogen's Non-Current Assets was $20.47 billion, down 0.6% from FY2024.
- Non-Current Assets carries a five-year compound annual growth rate of 2.9% (FY2020 to FY2025).
- Going back by year, Non-Current Assets was $20.59 billion in FY2024 (+3.0%), $19.99 billion in FY2023 (+35.4%), $14.76 billion in FY2022 (-7.9%) and $16.02 billion in FY2021 (-9.6%).
- The Q2 2026 figure represents the highest quarterly Non-Current Assets in data going back to Q2 2009.
- Year-over-year, Non-Current Assets increased in five of the last eight quarters, with growth averaging 4.1%.
- The fastest year-over-year change in Non-Current Assets over five years came in Q4 2023 (growth of 35.4%), and the weakest in Q2 2022 (a decline of 11.3%).
- Business Quant data shows BIIB's Non-Current Assets at $20.29 billion (Q1 2026), $20.47 billion (Q4 2025) and $20.27 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 77.61 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 141.07 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 101.45 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 125.00 Mn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 94.68 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 87.87 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 60.68 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 35.42 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 159.77 Bn |
| 10 | Biogen | 37.51 Bn | 24.16 Bn | 1.96 Bn | 24.78 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 24.78 Bn |
| Mar 31, 2026 | 20.29 Bn |
| Dec 31, 2025 | 20.47 Bn |
| Sep 30, 2025 | 20.27 Bn |
| Jun 30, 2025 | 20.36 Bn |
| Mar 31, 2025 | 20.41 Bn |
| Dec 31, 2024 | 20.59 Bn |
| Sep 30, 2024 | 21.48 Bn |
| Jun 30, 2024 | 19.70 Bn |
| Mar 31, 2024 | 19.81 Bn |
| Dec 31, 2023 | 19.99 Bn |
| Sep 30, 2023 | 19.74 Bn |
| Jun 30, 2023 | 14.73 Bn |
| Mar 31, 2023 | 14.84 Bn |
| Dec 31, 2022 | 14.76 Bn |
| Sep 30, 2022 | 15.09 Bn |
| Jun 30, 2022 | 15.34 Bn |
| Mar 31, 2022 | 15.70 Bn |
| Dec 31, 2021 | 16.02 Bn |
| Sep 30, 2021 | 16.64 Bn |
API Access
Biogen Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=BIIB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "BIIB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=BIIB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();